“…Therefore the concentrations of schistosome cfDNA in other body fluids such as urine (with the exception of S. haematobium which parasitises the bladder) and saliva, where direct contact with the parasite stages does not occur and the exact mechanisms of their release is yet unclear, cfDNA will be present in low amounts (Weerakoon and McManus, 2016). Hence, particularly in low intensity infections, cfDNA detection requires a highly sensitive diagnostic approach, using more technically advanced, novel DNA based methods, such as ddPCR (Hudecova, 2015;Miotke et al, 2014;Strain et al, 2013;Sze et al, 2014). When compared with cPCR and qPCR assays, ddPCR has higher diagnostic accuracy, and is able to provide absolute quantification, both features being beneficial in the support of disease control and elimination programs.…”